Results 111 to 120 of about 54,777 (206)

Vaccination against human papillomavirus.

Einstein (Sao Paulo, Brazil), 2013
Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.
openaire   +2 more sources

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. [PDF]

Hum Vaccin Immunother, 2022
Garland SM, Anagani M, Bhatla N, Chatterjee S, Lalwani S, Ross C, Group T, Lin J, Luxembourg A, Walia A, Tu Y.   +10 more
europepmc   +1 more source

Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial. [PDF]

Arch Dermatol Res, 2023
Fawzy M, Nofal E, Abdelkhalek N, Ehab R.
europepmc   +1 more source

Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income Countries. [PDF]

NEJM Evid, 2022
Eke AC, Kerry VB.
europepmc   +1 more source

On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students. [PDF]

Front Public Health, 2022
Zhou L, Gu B, Xu X, Li Y, Cheng P, Huo Y, Liu G, Zhang X.   +7 more
europepmc   +1 more source

Trends in the Utilization of Human Papillomavirus Vaccines and the Incidence of Malignant Cervical Cancer in Women and Teenagers: A Secondary Analysis. [PDF]

Healthcare (Basel), 2022
Luna M, Upadhyay S.
europepmc   +1 more source

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. [PDF]

, 2019
BackgroundHuman papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel,
Boland, Joseph, Cortes, Bernal, Cullen, Michael, CVT Group, Dunn, S Terence, Herrero, Rolando, Hildesheim, Allan, Kreimer, Aimée R, Mirabello, Lisa, Porras, Carolina, Quint, Wim, Roberson, David, Rodriguez, Ana Cecilia, Sampson, Joshua, Schiffman, Mark, Van Doorn, Leen-Jan, Wagner, Sarah, Walker, Joan, Wentzensen, Nicolas, Yeager, Meredith, Zuna, Rosemary   +20 more
core   +1 more source

The Role of Healthcare Providers in Promoting Human Papillomavirus Vaccines among Men Who Have Sex with Men: A Scoping Review. [PDF]

Vaccines (Basel), 2022
Chin KY, Ekeuku SO, Hamzah MR.
europepmc   +1 more source

Current Status of Human Papillomavirus Vaccines

Journal of the Formosan Medical Association, 2010
Barbara Ma, Richard Roden, T.-C. Wu
doaj   +1 more source

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use

Signal Transduction and Targeted Therapy
Human papillomaviruses, particularly high-risk human papillomaviruses, have been universally considered to be associated with the oncogenesis and progression of various cancers.
Yu Zhang, Ke Qiu, Jianjun Ren, Yu Zhao, Ping Cheng   +4 more
doaj   +1 more source